Where is the live CopyMark page for USPTO serial 76578222?

The live record is at https://getcopymark.com/trademark/76578222. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns DIBENZYLINE INJECTION?

According to the public USPTO record for serial number 76578222, the listed owner(s) include: Wellspring Pharmaceutical Corporation.

What is USPTO serial number 76578222?

Serial number 76578222 is the USPTO application identifier for the mark DIBENZYLINE INJECTION. It is used to track examination, publication, and registration of this trademark.

What is the current status of DIBENZYLINE INJECTION?

DIBENZYLINE INJECTION (76578222) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover DIBENZYLINE INJECTION?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: DIBENZYLINE INJECTION Serial# 76578222 | status 601; last event CORV | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DIBENZYLINE INJECTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Wellspring Pharmaceutical Corporation
Neptune, NJ
Other trademarks owned by Wellspring Pharmaceutical Corporation

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tara L. Benson

TARA L BENSON GIORDANO, HALLERAN & CIESLAPOST OFFICE BOX 190MIDDLETOWN, NJ 07748UNITED STATES

Goods and services

Class	Description	Status	First use
005	Sympatholytic and adrenolytic agent and as an agent affecting the central nervous system	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 12, 2009	CORV	REVIEW OF CORRESPONDENCE COMPLETE	—
Mar 14, 2008	MAIL	PAPER RECEIVED	—
Feb 5, 2008	MAIL	PAPER RECEIVED	—
Apr 22, 2005	MAB1	ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT	—
Apr 22, 2005	ABN1	ABANDONMENT - EXPRESS MAILED	—
Apr 7, 2005	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Nov 15, 2004	MAIL	PAPER RECEIVED	—
Nov 12, 2004	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Sep 24, 2004	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2004	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2004	DOCK	ASSIGNED TO EXAMINER	—
Mar 11, 2004	NWAP	NEW APPLICATION ENTERED	—

DIBENZYLINE INJECTION